SUPERNUS PHARMACEUTICALS INC (SUPN) Stock Analyst Earnings Estimates
NASDAQ:SUPN - Nasdaq - US8684591089 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 579.8M 11.41% | 667.2M 15.07% | 607.521M -8.94% | 655.76M 7.94% | 634.62M -3.22% | 699.25M 10.18% | 780.1M 11.56% | 848.15M 8.72% | 934.27M 10.15% | 944.72M 1.12% | 1.046B 10.72% | 1.187B 13.48% | |
| EBITDA YoY % growth | 140.9M -29.62% | 131.6M -6.60% | 99.779M -24.18% | 123.41M 23.68% | 168.76M 36.75% | 152.22M -9.80% | 177.68M 16.73% | 225.87M 27.12% | 319.67M 41.53% | 284.17M -11.11% | 246.02M -13.43% | 277.03M 12.60% | |
| EBIT YoY % growth | 108.3M -40.53% | 46.1M -57.43% | 14.92M -67.64% | 173.71M 1,064.28% | 114.2M -34.26% | 152.56M 33.59% | 217.35M 42.47% | 272.16M 25.22% | 360.16M 32.33% | 347.41M -3.54% | 374.75M 7.87% | 432.89M 15.51% | |
| Operating Margin | 18.68% | 6.91% | 2.46% | 26.49% | 18.00% | 21.82% | 27.86% | 32.09% | 38.55% | 36.77% | 35.83% | 36.47% | |
| EPS YoY % growth | 0.98 -58.47% | 1.03 5.10% | 1.40 35.92% | 2.91 108.13% | 1.93 -33.72% | 2.38 23.24% | 3.27 37.36% | 4.13 26.37% | 5.10 23.46% | 4.95 -3.00% | 5.30 7.22% | 6.12 15.38% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.53 -40.40% | 0.42 62.15% | 0.48 33.17% | 0.53 -22.64% | 0.56 5.77% |
| Revenue Q2Q % growth | 157.62M -4.07% | 145.81M 1.51% | 155.24M -7.77% | 162.26M -7.64% | 167.71M 6.40% |
| EBITDA Q2Q % growth | 34.384M -66.95% | 44.37M 152.16% | 44.574M -30.39% | 49.572M -51.60% | 47.022M 36.76% |
| EBIT Q2Q % growth | 31.676M 65.04% | 24.412M 874.25% | 30.872M 36.79% | 34.918M -14.51% | 39.372M 24.30% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.69 187.50% | 0.45 | 0.24 | 52.59% |
| Q2 2024 Q2Q % growth | 0.36 1,900.00% | 0.40 | -0.04 | -9.50% |
| Q1 2024 Q2Q % growth | 0.26 -10.34% | 0.38 | -0.12 | -32.33% |
| Q4 2023 Q2Q % growth | 0.89 106.98% | 0.56 | 0.33 | 57.69% |
| Q3 2023 Q2Q % growth | 0.24 700.00% | 0.08 | 0.16 | 194.12% |
| Q2 2023 Q2Q % growth | -0.02 -114.29% | 0.07 | -0.09 | -130.17% |
| Q1 2023 Q2Q % growth | 0.29 -32.56% | 0.17 | 0.12 | 67.24% |
| Q4 2022 Q2Q % growth | 0.43 975.00% | 0.69 | -0.26 | -38.00% |
| Q3 2022 Q2Q % growth | 0.03 -92.50% | 0.36 | -0.33 | -91.75% |
| Q2 2022 Q2Q % growth | 0.14 -67.44% | 0.30 | -0.16 | -52.67% |
| Q1 2022 Q2Q % growth | 0.43 290.91% | 0.24 | 0.19 | 75.65% |
| Q4 2021 Q2Q % growth | 0.04 -92.98% | 0.24 | -0.20 | -83.43% |
| Q3 2021 Q2Q % growth | 0.40 -45.95% | 0.24 | 0.16 | 68.67% |
| Q2 2021 Q2Q % growth | 0.43 -33.85% | 0.20 | 0.23 | 113.45% |
| Q1 2021 Q2Q % growth | 0.11 -72.50% | 0.25 | -0.14 | -55.53% |
| Q4 2020 Q2Q % growth | 0.57 -8.06% | 0.53 | 0.04 | 7.99% |
| Q3 2020 Q2Q % growth | 0.74 37.04% | 0.30 | 0.44 | 143.86% |
| Q2 2020 Q2Q % growth | 0.65 6.56% | 0.43 | 0.22 | 51.73% |
| Q1 2020 Q2Q % growth | 0.40 17.65% | 0.29 | 0.11 | 39.06% |
| Q4 2019 Q2Q % growth | 0.62 | 0.62 | 0.00 | 0.75% |
| Q3 2019 Q2Q % growth | 0.54 | 0.61 | -0.07 | -11.76% |
| Q2 2019 Q2Q % growth | 0.61 | 0.59 | 0.02 | 3.11% |
| Q1 2019 Q2Q % growth | 0.34 | 0.48 | -0.14 | -29.45% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 175.689M 14.17% | 160.44M | 15.249M | 9.50% |
| Q2 2024 Q2Q % growth | 168.325M 24.17% | 151.83M | 16.495M | 10.86% |
| Q1 2024 Q2Q % growth | 143.644M -6.58% | 148.75M | -5.106M | -3.43% |
| Q4 2023 Q2Q % growth | 164.314M -1.78% | 158.13M | 6.184M | 3.91% |
| Q3 2023 Q2Q % growth | 153.88M -13.26% | 146.25M | 7.63M | 5.22% |
| Q2 2023 Q2Q % growth | 135.563M -20.30% | 146.53M | -10.967M | -7.48% |
| Q1 2023 Q2Q % growth | 153.764M 0.83% | 141.8M | 11.964M | 8.44% |
| Q4 2022 Q2Q % growth | 167.3M 5.15% | 183.98M | -16.68M | -9.07% |
| Q3 2022 Q2Q % growth | 177.4M 19.46% | 175.93M | 1.47M | 0.84% |
| Q2 2022 Q2Q % growth | 170.1M 20.38% | 167.51M | 2.59M | 1.55% |
| Q1 2022 Q2Q % growth | 152.5M 16.50% | 153.48M | -980K | -0.64% |
| Q4 2021 Q2Q % growth | 159.1M 10.79% | 155.77M | 3.33M | 2.14% |
| Q3 2021 Q2Q % growth | 148.5M -4.26% | 144.96M | 3.54M | 2.44% |
| Q2 2021 Q2Q % growth | 141.3M 11.52% | 137.57M | 3.73M | 2.71% |
| Q1 2021 Q2Q % growth | 130.9M 37.79% | 131.78M | -880K | -0.67% |
| Q4 2020 Q2Q % growth | 143.6M 43.03% | 149.11M | -5.51M | -3.70% |
| Q3 2020 Q2Q % growth | 155.1M 51.91% | 133.27M | 21.83M | 16.38% |
| Q2 2020 Q2Q % growth | 126.7M 21.01% | 100.06M | 26.64M | 26.62% |
| Q1 2020 Q2Q % growth | 95M 11.11% | 85.151M | 9.849M | 11.57% |
| Q4 2019 Q2Q % growth | 100.4M | 113.76M | -13.36M | -11.74% |
| Q3 2019 Q2Q % growth | 102.1M | 112.03M | -9.93M | -8.86% |
| Q2 2019 Q2Q % growth | 104.7M | 111.89M | -7.19M | -6.43% |
| Q1 2019 Q2Q % growth | 85.5M | 105.65M | -20.15M | -19.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4% | 12.23% | 0% | 41.42% |
| Revenue | 0.59% | 0.17% | 0.12% | 3.78% |